Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule with the chemical formula C16H12ClN3O2S and a molecular weight of approximately 345.8 g/mol. It is known as an experimental drug and has been referenced in chemical databases such as DrugBank (DB07066) and PubChem (CID:15991547). The structure features a thienopyrrole core substituted with a chloro group and linked to a tetrahydroquinoline moiety via an amide bond. There is no publicly available information on its mechanism of action or therapeutic indication; it appears to be primarily studied as a research chemical or lead compound for further drug development rather than as an approved pharmaceutical agent[1][2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 2-chloro-N-[(3R)-2-oxo-1,2,3,4-tetrahydroquinolin-3-yl]-6H-thieno[2,3-b]pyrrole-5-carboxamide.